Bausch Health Companies Inc
BHC
Market Cap$2.21B
Close$
$4.87
18.6% downside
Current Fair Value
18.6% downsideOvervalued by 18.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.21 Billion |
|---|---|
| Enterprise Value | $1.08 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.13 |
| Beta | 0.28 |
| Outstanding Shares | 362,500,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -50.86 |
|---|---|
| PEG | 567.07 |
| Price to Sales | 0.23 |
| Price to Book Ratio | 0.08 |
| Enterprise Value to Revenue | 0.11 |
| Enterprise Value to EBIT | 0.7 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bausch Health Companies Inc
21,100 employeesBausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...